<DOC>
	<DOCNO>NCT02686268</DOCNO>
	<brief_summary>This research study perform good understand specific form Amyotrophic Lateral Sclerosis ( ALS ) cause mutation ( abnormality ) C9ORF72 gene . This mutation common genetic cause ALS , present 40 % ALS patient family history ALS 5-10 % ALS patient without family history ALS .</brief_summary>
	<brief_title>Understanding Clinical Phenotype Collecting Biomarker Samples C9ORF72 ALS</brief_title>
	<detailed_description>Individuals diagnose ALS , confirm carry Chromosome 9 Open Reading Frame 72 ( C9ORF72 ) gene mutation CLIA-certified lab result , eligible enrollment . Researchers want understand natural history C9ORF72 related ALS term measure rate progression well understanding size hexanucleotide repeat expansion influence disease parameter . The investigator hope intense study patient C9ORF72 mutation ultimately help u develop treatment common form ALS . Objectives : - Enroll total 120 C9ORF72 ALS participant know mutation time enrollment . - Determine C9ORF72 hexanucleotide repeat expansion size subject - Define ALS disease course - Determine degree disease course correlate expansion size - Collect biomarker sample ( blood , DNA CSF ) Eligibility : - Adults age 18 know C9ORF72 ALS status Design : Participants 9 in-person visit ( include two Optional visit lumbar puncture procedure ) 5 telephone interview 3 year . Each in-person visit may tie regular clinic visit subject local ( except optional lumbar puncture visit ) subject town one initial visit set visit perform via telephone call medical record review . At town visit , subject undergo blood draw ( optional lumbar puncture ) two questionnaire ( ALS Functional Rating Scale - revise ALSFRS-R ) measure motor function ALS-Cognitive Behavioral Screen ( ALS-CBS ) detect sign Frontal Temporal Dementia breathe test determine Slow Vital Capacity ( SVC ) measurement . For town subject - blood draw schedule locally send study site analysis . The ALSFRS-R perform phone along study related question . The C9ORF72 mutation call `` dominant '' mutation , mean child 50 % chance inherit gene . Most people inherit C9ORF72 mutation develop either ALS relate disease call fronto-temporal dementia . However , may possible someone test positive C9ORF72 gene mutation never develop symptom . Furthermore , addition C9ORF72 , many gene mutation cause ALS . This study test gene , therefore negative test result C9ORF72 mutation exclude possibility heritable form ALS . In order understand natural history C9ORF72 related ALS term measure rate progression , investigator need understand size hexanucleotide repeat expansion influence disease parameter . A C9ORF72-focused clinical trial define accurate historical control population , critical since may enough subject placebo control trial . To ready upcoming therapeutic trial , investigator need start detailed characterization C9ORF72 patient immediately .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Inclusion : 1 . Males females race age 18 old 2 . Known positive C9ORF72 ALS status via CLIAcertified lab result . 3 . Capable provide informed consent follow study procedure . In event individual lack ability provide inform consent , inform consent may seek individual 's legal , surrogate representative . 4 . Geographically accessible site . Exclusion : 1 . Geographically inaccessible site 2 . C9ORF72 ALS negative via CLIAcertified lab result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>ALS</keyword>
	<keyword>C9ORF72 gene mutation</keyword>
	<keyword>Chromosome 9 open reading frame 72 protein</keyword>
	<keyword>Natural history</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Amyotrophic Lateral Sclerosis , Familial</keyword>
	<keyword>Amyotrophic Lateral Sclerosis , Sporadic</keyword>
	<keyword>Frontotemporal Dementia-Amyotrophic Lateral Sclerosis</keyword>
</DOC>